在肝细胞癌中,MEX3A通过调节RORA/β-catenin通路促进细胞增殖
Peng-Xiang Ji1, Ping Zhang1, Hui-Ling Zhou2
1Hand Surgery Laboratory, Suzhou Ruihua Orthopedic Hospital, Suzhou Medical College of Soochow University, Suzhou 215104, Jiangsu Province, China.
World journal of gastrointestinal oncology
|April 16, 2025
概括
MEX3A通过通过RORA/β-catenin通路增强细胞增殖和迁移,促进肝细胞癌 (HCC) 的进展. 这项研究确定MEX3A作为HCC患者的潜在预后标志物和治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 作为MEX-3基因家族的一员,MEX3A与各种癌症中的细胞增殖和迁移有关.
- 它在肝细胞癌 (HCC) 中的具体作用尚不清楚,需要进一步研究.
研究的目的:
- 研究MEX3A在HCC中的表达和临床意义.
- 探索MEX3A在HCC瘤进展中的作用及其潜在的分子机制.
主要方法:
- 使用TCGA数据对HCC组织中MEX3AmRNA表达的分析与邻近组织的分析.
- 免疫组织化学验证MEX3A表达并将其与临床参数相关联.
- 功能性研究涉及MEX3A在HCC细胞系中被淘汰,以评估增殖,细胞周期,迁移和Wnt/β-catenin通路活性.
- 研究RORA在调解MEX3A效应中的作用.
主要成果:
- 在HCC组织中,MEX3A的表达显著上调,并与较差的整体存活率有关.
- MEX3A倒置抑制了HCC细胞的增殖,细胞循环的进展和迁移.
- MEX3A通过激活RORA/β-catenin信号通路来促进HCC的进展.
- MEX3A表达与HBV阳性,瘤分化和瘤大小相关.
结论:
- MEX3A通过RORA/β-catenin通路促进HCC细胞的增殖和进展.
- MEX3A代表了肝细胞癌的潜在预后生物标志物和治疗点.
更多相关视频
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
264
08:18Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
Published on: December 31, 2014
27.8K
相关概念视频
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
MAPK Signaling Cascades
5.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.0K
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
The Ras Gene
6.1K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.1K
